EPFL
How EPFL will make the most of its carbon emissions
TechTransfer
EPFL
By supporting a large-scale research project for carbon capture, utilization and storage, EPFL will shrink its carbon footprint while giving a boost to emerging technology.
Antibody-peptide inhibitor conjugates: a new path for cancer therapy
Research
EPFL
Cancer treatments often struggle with balancing efficacy and side effects. A new study by EPFL scientists offers a promising solution using antibody-peptide inhibitor conjugates to target specific cell types and block the activity of cancer-promoting enzymes called cathepsins.
Scientists map biodiversity changes in the world's forests
Research
EPFL
A group of EPFL and ETH Zurich scientists have mapped the biodiversity in forests worldwide. Their data, when combined with climate projections, reveal trends that could support ecosystem conservation and restoration efforts.
The bright future of solar energy
Politics
EPFL
Solar energy, which is both abundant and free, is poised to become the world’s leading power source by 2050. That’s thanks largely to technological advances and the unbridled manufacturing of solar cells, which bodes well for a successful energy transition.
Gamma-ray method monitors nuclear reactors safely and quickly
Research
EPFL
Scientists at EPFL have devised and tested out a new, gamma-noise method for monitoring nuclear reactors non-invasively and from a distance. The new method, tested out on EPFL’s CROCUS nuclear reactor, can improve nuclear safety and treaty compliance.
An AI leap into chemical synthesis
Research
EPFL
EPFL scientists introduce ChemCrow, a large language model-based AI system that revolutionizes chemistry by integrating 18 advanced tools for tasks like organic synthesis and drug discovery. ChemCrow streamlines complex processes in chemical research, making it more efficient for experts and novices alike.
Page 21 of 64